BioNexus Gene Lab Corp BGLC:OTCQB

RT Quote | Exchange | USD
Last | 06/29/22 EDT
1.14UNCH (UNCH)
52 week range
0.78 - 2.25
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.14
  • 52 Week High2.25
  • 52 Week High Date10/20/21
  • 52 Week Low0.78
  • 52 Week Low Date10/20/21

Key Stats

  • Market Cap195.19M
  • Shares Out171.22M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-46.48

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.14
  • 52 Week High2.25
  • 52 Week High Date10/20/21
  • 52 Week Low0.78
  • 52 Week Low Date10/20/21
  • Market Cap195.19M
  • Shares Out171.22M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-46.48

RATIOS/PROFITABILITY

  • EPS (TTM)0.00
  • P/E (TTM)454.18
  • Fwd P/E (NTM)-
  • EBITDA (TTM)851,360.00
  • ROE (TTM)6.18%
  • Revenue (TTM)12.94M
  • Gross Margin (TTM)15.03%
  • Net Margin (TTM)3.32%
  • Debt To Equity (MRQ)0.48%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On BioNexus Gene Lab Corp

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
BioNexus Gene Lab Corp. is an emerging molecular diagnostics company. The Company is focused on the application of functional genomics to enable early diagnosis and personalized health management. The Company's wholly owned subsidiaries include Bionexus Gene Lab Sdn. Bhd. (Bionexus Malaysia) and Chemrex Sdn. Bhd. (Chemrex). BioNexus Malaysia owns algorithm software, technology and know-how related to the detection of common diseases through blood analysis which it uses in its...
Address
Tower B, Vertical Business Suite, 10-2,
Kuala Lumpur
59200
Malaysia